Hangzhou Tigermed Consulting Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Hangzhou, Zhejiang and currently employs 11,130 full-time employees. The company went IPO on 2012-08-17. Hangzhou Tigermed Consulting Co Ltd is a China-based holding company engaged in providing clinical trial services for research and development of new drugs. The firm operates two segments. The Clinical Trial Solutions segment provides clinical trial operation services and medical translation services to biopharmaceutical and medical device companies and thus help them conduct clinical trials of innovative drugs, generic drugs and medical devices. The Clinical-Related and Laboratory Services segment is involved in provision of analytical services, such as data management and statistical analysis; logistics and execution support services, such as clinical trial site management; administrative assistance, such as patient recruitment; as well as consulting services. This segment also provides laboratory services for preclinical and clinical development stages through its subsidiary. The firm conducts its businesses in the domestic and overseas markets.
Milyon USD cinsinden finanslar. Mali yıl Şubat - Ocak'tır.
Breakdown
TTM
03/31/2026
12/31/2025
09/30/2025
06/30/2025
03/31/2025
Hasılat
7,070
1,801
1,806
1,775
1,686
1,564
Hasılat Artışı (YoY)
9%
15%
18%
4%
-1%
-6%
Satınalma Maliyeti
5,223
1,330
1,408
1,297
1,187
1,101
Brüt Kâr
1,846
471
398
478
498
462
Satış, Genel ve İdari
950
232
225
244
247
240
Araştırma ve Geliştirme
261
62
66
64
67
59
İşletme Giderleri
1,193
274
305
305
308
289
Diğer Finansman Gelirleri (Giderleri)
-5
0
0
-4
0
0
Kâr Öncesi Gelir
1,265
405
-219
780
299
143
Kira Vergisi Gideri
240
75
67
51
46
33
Net Kâr
771
49
-132
637
217
165
Net Income Growth
Kâr Artışı
130%
-70%
-68%
99%
-16%
-30%
Dolaşım Daki Hisse Senetleri (Dilüte Edilmiş)
817.38
817.38
850.96
868.8
832.83
870.88
Hisse Değişimi (Yıllık Üst Üste)
-6%
-6%
-1%
0%
-3%
0%
EPS (Diluted)
0.94
0.06
-0.15
0.73
0.26
0.19
EPS Artışı
144%
-68%
-67%
98%
-13%
-30%
Öz sermaye akışı
1,021
267
337
258
157
149
Hisse Başı Öz Kaynak Akışı
--
--
--
--
--
--
Brüt Karşılık
26.11%
26.15%
22.03%
26.92%
29.53%
29.53%
Faaliyet Kâr Marjı
9.23%
10.88%
5.14%
9.69%
11.26%
10.99%
Kâr Marjı
10.9%
2.72%
-7.3%
35.88%
12.87%
10.54%
Özsermaye Karlılık Oranı
14.44%
14.82%
18.66%
14.53%
9.31%
9.52%
EBITDA
--
--
--
--
--
--
EBITDA Marjinali
--
--
--
--
--
--
D&A EBITDA için
--
--
--
--
--
--
Faaliyet Kârı
653
196
93
172
190
172
Faaliyet Kâr Marjı
9.23%
10.88%
5.14%
9.69%
11.26%
10.99%
Verilen Vergi Oranı
18.97%
18.51%
-30.59%
6.53%
15.38%
23.07%
Follow-Up Questions
Hangzhou Tigermed Consulting Co., Ltd'in temel mali tabloları nelerdir?
Son mali tabloya (Form-10K) göre, Hangzhou Tigermed Consulting Co., Ltd'in toplam varlıkları $0 olup, net kayıp $0'dir.
HNGZY'ün temel finansal oranları nelerdir?
Hangzhou Tigermed Consulting Co., Ltd'in cari oranı 0, net kâr marjı 0, hisse başına satış $0'dir.
Hangzhou Tigermed Consulting Co., Ltd'in geliri segment veya coğrafya bazında nasıl dağılıyor?
Hangzhou Tigermed Consulting Co., Ltd en büyük gelir kaynağı Clinical Trial Related Services and Laboratory Services olup, en son kar bildiriminde geliri 3,446,527,556 dir. Coğrafi olarak, China , Hangzhou Tigermed Consulting Co., Ltd için ana pazar olup, geliri 3,705,266,993 dir.
Hangzhou Tigermed Consulting Co., Ltd kârlı mı?
hayır, son mali tablolara göre Hangzhou Tigermed Consulting Co., Ltd'in net kayıp $0'dir.
Hangzhou Tigermed Consulting Co., Ltd'in herhangi bir yükümlülüğü var mı?